BSE Live
Dec 30, 16:01Prev. Close
1433.75
Open Price
1434.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 30, 15:57Prev. Close
1434.60
Open Price
1440.00
Bid Price (Qty.)
1386.20 (1952)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Ipca Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,131.14 | 842.67 | 745.29 | 1,135.72 | 1,388.98 | |
| Net CashFlow From Operating Activities | 1,321.32 | 944.65 | 805.81 | 856.04 | 1,090.13 | |
| Net Cash Used In Investing Activities | -869.50 | -1,291.79 | -725.00 | -855.05 | -520.69 | |
| Net Cash Used From Financing Activities | -282.98 | -552.55 | 507.24 | 426.81 | -305.82 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 76.50 | 0.00 | 4.12 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 168.84 | -823.19 | 588.05 | 431.92 | 263.62 | |
| Cash And Cash Equivalents Begin of Year | 755.79 | 1,578.98 | 990.93 | 559.01 | 295.39 | |
| Cash And Cash Equivalents End Of Year | 924.63 | 755.79 | 1,578.98 | 990.93 | 559.01 |
05.12.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
17.11.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
13.07.2022
Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct
08.07.2022
Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher
14.04.2022
Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
13.01.2022
Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher